A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5

Blood

Volumn 87, Issue 4, 1996, Pages 1416-1422

  Brugnoni, Duilio ^b   Airò, Paolo ^a   Rossi, Giuseppe ^b   Bettinardi, Alessandra ^b   Simon, Hans Uwe ^b   Garza, Lucia ^b   Tosoni, Cinzia ^b   Cattaneo, Roberto ^b   Blaser, Kurt ^b   Tucci, Alessandra ^b  

^a SPEDALI CIVILI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOCYTE SURFACE MARKER; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ; T LYMPHOCYTE RECEPTOR;

AGED; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CONTROLLED STUDY; GENE EXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; IMMUNOPHENOTYPING; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION;

EID: 13344259994     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1416.bloodjournal8741416     Document Type: Article

References (34)

1. Basten A, Beeson PB: Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med 131:1288, 1970
2. Weller PF, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood 83:2759, 1994
3. Romagnani S: Human Th1 and Th2 subsets: Doubt no more. Immunol Today 12:256, 1991
4. Sanderson CJ: Interleukin-5, eosinophils and disease Blood 79:3101, 1992
5. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227, 1994
6. Owen WF, Rothenberg ME, Petersen J, Weller PF, Silberstein D, Sheffer AL, Stevens RL, Soberman RJ, Austen KF: Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:343, 1989
7. Enokihara H, Kajitani H, Nagashima S, Tsunogake S, Takano N, Saito K, Furusawa S, Shishido H, Hitoshi Y, Takatsu K: Interleukin 5 activity in sera from patients with eosinophilia. Br J Haematol 75:458, 1990
8. Screzenmeier H, Home SD, Tewald F, Fleischer B, Raghavachar A: Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 21:358, 1993
9. Simon HU, Blaser K: Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia? Immunol Today 16:53, 1995
10. Yousefi S, Green Dr, Blaser K, Simon HU: Protein tyrosin phosphorylation regulates apoptosis in human eosinophils and neutrophils. Proc Natl Acad Sci USA 91:10868, 1994
11. O'Shea JJ, Jaffe ES, Lane HC, MacDermott RP, Fauci AS: Peripheral T-cell lymphoma presenting as hypereosinophilia with vasculitis. Am J Med 82:539, 1987
12. Chott AC, Augustin I, Wrba F, Hanak H, Ohlinger W, Radaskiewicz T: Peripheral T-cell lymphomas: A clinico-pathological study of 75 cases. Hum Pathol 21.1117, 1990
13. Bagot M, Bodemer C, Wechsler J, Divine M, Haioun C, Capesius C, Saal F, Cabotin P, Roubertie E, De Prost Y, Lorette G, Revuz J: Lymphome T non épidermotrope précédé pendant plusieurs années par un syndrome hyperéosinophilique. Ann Dermatol Venereol 117:883, 1990
14. Moraillon I, Bagot M, Bournerias I, Prin L, Wechsler J, Revuz J: Syndrome Hypereosinophilique avec pachydermie précédant un lymphome. Traitement par l'interféron alpha. Ann Dermatol Venereol 118:883, 1991
15. Kim CJ, Park SH, Chi JG: Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma. Cancer 67:1064, 1991
16. Abruzzo LV, Jaffe ES, Coteligam JD, Whang-Peng J, Del-Duca VJ, Medeiros LJ: T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy. Am J Surg Pathol 16:236, 1992
17. Murata K, Yamada Y, Karmhara S, Atogami S, Tsukasaki K, Momita S, Amagasaki T, Sadamori N, Tomonaga M, Kinoshita KI, Ichimaru M: Frequency of eosinophilia in adult T-cell leukemia/ lymphoma. Cancer 69:966, 1992
18. Vowels BR, Cassin M, Vonderheid EC, Rook AH: Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99:90, 1992
19. Samoszuk M, Ramzi E, Cooper DL: Interleukin-5 mRNA in three T-cell lymphomas with eosinophilia. Am J Hematol 42:402, 1993
20. Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type-2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 330:535, 1994
21. Brugnom D, Airò P, Graf D, Marconi M, Lebowitz M, Plebani A, Giliani S, Malacame F, Cattaneo R, Ugazio AG, Albertini A, Kroczek RA, Notarangelo LD: Ineffective expression of CD40 ligand on cord blood T cells may contribute to poor immunoglobulin production in the newborn. Eur J Immunol 24:1919, 1994
22. Carballido JM, Carballido-Perrig N, Terres G, Heusser CH, Blaser K: Bee venom phospholipase A2-specific T cell clones from human allergic and non-allergic individuals: Cytokine patterns change in response to the antigen concentration. Eur J Immunol 22:1357, 1992
23. Andersson U, Andersson J, Lindfors A, Wagner K, Moller G, Heusser CH: Simultaneous production of interleukin 2, interleukin 4 and interferon-γ by activated human blood lymphocytes. Eur J Immunol 20:1591, 1990
24. Gillis S, Ferm MM, Du W, Smith KA: T cell growth factor: Parameters of production and a quantitative microassay for activity. J Immunol 120:2027, 1978
25. Simon HU, Tsao PW, Siminovitch KA, Mills GB, Blaser K: Functional platelet-activating factor receptors are expressed by monocytes are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma. J Immunol 153:364, 1994
26. Yousefi S, Hemman S, Weber M, Hoelzer C, Hartung K, Blaser K, Simon HU: IL-8 is expressed by human peripheral blood eosinophils. Evidence for increase secretion in asthma. J Immunol 154:5481, 1995
27. Flug F, Pelicci PG, Bonetti F, Knowles DMI, Dalla Favera R: T cell receptor gene rearrangement as markers of lineage and clonality in T cell neoplasms. Proc Natl Acad Sci USA 82:3460, 1985
28. Martin R, Howell MD, Jaraquemada D, Flerlage M, Richert J, Brostoff S, Long EO, McFarlin DE, McFarland HF: A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173:19, 1991
29. Bettinardi A, Imberti L, Sottini A, Primi D: Analysis of amplified T cell receptor Vβ transcripts by a non-isotopic immunoassay. J Immunol Methods 146:71, 1992
30. Picker LJ, Brenner MB, Weiss LM, Smith SD, Warnke RA: Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas. Am J Pathol 129:434, 1987
31. Hintzen RQ, de Jong R, Lens SMA, van Lier RAW: CD27: Marker and mediator of T-cell activation? Immunol Today 15:307, 1994
32. Weiss LM, Picker LJ, Grogan TM, Warnke RA, Sklar J: Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol 130:436, 1988
33. Bohjanen PR, Okaijma M, Hodes RJ: Differential regulation of interleukin-4 and interleukin 5 gene expression: A comparison of T-cell induction by anti-CD3 antibody or by exogenous lymphokines. Proc Natl Acad Sci USA 87:5283, 1990
34. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr: Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 146:109, 1992